Literature DB >> 35320416

MDC1 is essential for G2/M transition and spindle assembly in mouse oocytes.

Jiyeon Leem1, Jeong Su Oh2,3.   

Abstract

Mammalian oocytes are particularly susceptible to accumulating DNA damage. However, unlike mitotic cells in which DNA damage induces G2 arrest by activating the ATM-Chk1/2-Cdc25 pathway, oocytes readily enter M-phase immediately following DNA damage. This implies a lack of a robust canonical G2/M DNA damage checkpoint in oocytes. Here we show that MDC1 plays a non-canonical role in controlling G2/M transition by regulating APC/C-Cdh1-mediated cyclin B1 degradation in response to DNA damage in mouse oocytes. Depletion of MDC1 impaired M-phase entry by decreasing cyclin B1 levels via the APC/C-Cdh1 pathway. Notably, the APC/C-Cdh1 regulation mediated by MDC1 was achieved by a direct interaction between MDC1 and APC/C-Cdh1. This interaction was transiently disrupted after DNA damage with a concomitant increase in Cdh1 levels, which, in turn, decreased cyclin B1 levels and delayed M-phase entry. Moreover, MDC1 depletion impaired spindle assembly by decreasing the integrity of microtubule organizing centers (MTOCs). Therefore, our results demonstrate that MDC1 is an essential molecule in regulating G2/M transition in response to DNA damage and in regulating spindle assembly in mouse oocytes. These results provide new insights into the regulation of the G2/M DNA damage checkpoint and cell cycle control in oocytes.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  APC/C-Cdh1; DNA damage; G2/M transition; MDC1; Oocytes; Spindle assembly

Mesh:

Substances:

Year:  2022        PMID: 35320416     DOI: 10.1007/s00018-022-04241-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  34 in total

1.  MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.

Authors:  Manuel Stucki; Julie A Clapperton; Duaa Mohammad; Michael B Yaffe; Stephen J Smerdon; Stephen P Jackson
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 2.  ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.

Authors:  Andrew N Blackford; Stephen P Jackson
Journal:  Mol Cell       Date:  2017-06-15       Impact factor: 17.970

3.  Wee1B is an oocyte-specific kinase involved in the control of meiotic arrest in the mouse.

Authors:  Seung Jin Han; Ruby Chen; Maria Paola Paronetto; Marco Conti
Journal:  Curr Biol       Date:  2005-09-20       Impact factor: 10.834

Review 4.  DNA damage checkpoints: from initiation to recovery or adaptation.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

5.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

6.  MDC1 is a mediator of the mammalian DNA damage checkpoint.

Authors:  Grant S Stewart; Bin Wang; Colin R Bignell; A Malcolm R Taylor; Stephen J Elledge
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

7.  MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Xianglin Wu; Junjie Chen
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

Review 8.  Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.

Authors:  Sophie E Polo; Stephen P Jackson
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

Review 9.  Double-strand break repair: 53BP1 comes into focus.

Authors:  Stephanie Panier; Simon J Boulton
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

Review 10.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.